{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:23:42Z","timestamp":1792117422814,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012021","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T00:00:00Z","timestamp":1505692800000}}],"reference-count":191,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012021.pub2","type":"journal-article","created":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T19:46:58Z","timestamp":1505764018000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs"],"prefix":"10.1002","volume":"2017","author":[{"given":"Lucy","family":"Platt","sequence":"first","affiliation":[{"name":"London School of Hygiene and Tropical Medicine; Department of Social and Environmental Health Research; 15 - 17 Tavistock Place London UK WC1H 9SH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Minozzi","sequence":"additional","affiliation":[{"name":"Lazio Regional Health Service; Department of Epidemiology; Via Cristoforo Colombo, 112 Rome Italy 00154"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Reed","sequence":"additional","affiliation":[{"name":"New York University College of Nursing; New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vickerman","sequence":"additional","affiliation":[{"name":"University of Bristol; School of Social and Community Medicine; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Hagan","sequence":"additional","affiliation":[{"name":"New York University College of Nursing; New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"French","sequence":"additional","affiliation":[{"name":"University of Bristol; School of Social and Community Medicine; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashly","family":"Jordan","sequence":"additional","affiliation":[{"name":"New York University College of Nursing; New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Degenhardt","sequence":"additional","affiliation":[{"name":"UNSW; National Drug and Alcohol Research Centre; Building R3 22-32 King Street Randwick NSW Australia 2031"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Hope","sequence":"additional","affiliation":[{"name":"Liverpool John Moores University; Public Health Institute; Liverpool UK L3 2ET"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Hutchinson","sequence":"additional","affiliation":[{"name":"Health Protection Scotland; Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Maher","sequence":"additional","affiliation":[{"name":"Kirby Institute, University of New South Wales; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah","family":"Palmateer","sequence":"additional","affiliation":[{"name":"Health Protection Scotland; Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avril","family":"Taylor","sequence":"additional","affiliation":[{"name":"University of West of Scotland; Paisley UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[{"name":"University of Montreal; Department of Family and Emergency Medicine; Montreal Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[{"name":"University of Bristol; School of Social and Community Medicine; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,9,18]]},"reference":[{"key":"10.1002\/14651858.CD012021.pub2-BIB0001|cit1","unstructured":"Unpublished dataset [personal communication] Email to: Paul Dietz"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0002|cit2","unstructured":"Unpublished dataset [personal communication] Email to: Julie Bruneau"},{"issue":"9","key":"10.1002\/14651858.CD012021.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1017\/S095026880900212X","article-title":"Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size","volume":"137","author":"Craine","year":"2009","journal-title":"Epidemiology and Infection"},{"issue":"8","key":"10.1002\/14651858.CD012021.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1360-0443.1997.tb02979.x","article-title":"Methadone maintenance and hepatitis C virus infection among injecting drug users","volume":"92","author":"Crofts","year":"1997","journal-title":"Addiction"},{"issue":"11","key":"10.1002\/14651858.CD012021.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2105\/AJPH.85.11.1531","article-title":"Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program","volume":"85","author":"Hagan","year":"1995","journal-title":"American Journal of Public Health"},{"issue":"3","key":"10.1002\/14651858.CD012021.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a009792","article-title":"Syringe exchange and risk of infection with hepatitis B and C viruses","volume":"149","author":"Hagan","year":"1999","journal-title":"American Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ypmed.2009.04.014","article-title":"The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004","volume":"49","author":"Holtzman","year":"2009","journal-title":"Preventive Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2893.2010.01297.x","article-title":"Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots","volume":"18","author":"Hope","year":"2011","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0009|cit9","unstructured":"Unpublished dataset [personal communication] Email to: Vivian Hope"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0010|cit10","unstructured":"Unpublished dataset [personal communication] Email to: Ali Judd"},{"issue":"HS1","key":"10.1002\/14651858.CD012021.pub2-BIB0011|cit11","first-page":"1S15","article-title":"Incidence and risk factors of HCV infection in a cohort of intravenous drug users in the North and East of France","volume":"54","author":"Bruandet","year":"2006","journal-title":"Revue d'Epidemiologie et de Sante Publique"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1017\/S095026880400247X","article-title":"Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France","volume":"132","author":"Lucidarme","year":"2004","journal-title":"Epidemiology and Infection"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0013|cit13","unstructured":"Unpublished dataset [pers comm] Email to: Meghan Morris"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0014|cit14","unstructured":"Unpublished dataset [personal communication] Email to: Shruti Mehta"},{"issue":"12","key":"10.1002\/14651858.CD012021.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1111\/add.12682","article-title":"The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users","volume":"109","author":"Nolan","year":"2014","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0016|cit16","unstructured":"Unpublished dataset [personal communication] Email to: Kimberly Page"},{"issue":"5","key":"10.1002\/14651858.CD012021.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.drugpo.2012.07.006","article-title":"Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland","volume":"23","author":"Allen","year":"2012","journal-title":"International Journal on Drug Policy"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/jvh.12117","article-title":"Risk of transmission associated with sharing drug injecting paraphernalia: Analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data","volume":"21","author":"Palmateer","year":"2014","journal-title":"Journal of Viral Hepatitis"},{"issue":"8","key":"10.1002\/14651858.CD012021.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"e104515","DOI":"10.1371\/journal.pone.0104515","article-title":"Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions","volume":"9","author":"Palmateer","year":"2014","journal-title":"PLOS ONE"},{"issue":"7","key":"10.1002\/14651858.CD012021.pub2-BIB0020|cit20","first-page":"889","article-title":"Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection","volume":"165","author":"Patrick","year":"2001","journal-title":"Canadian Medical Association Journal"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/00365549609027145","article-title":"Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence","volume":"28","author":"Rezza","year":"1996","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1258\/095646207779949880","article-title":"High hepatitis C virus prevalence and incidence among Canadian intravenous drug users","volume":"18","author":"Roy","year":"2007","journal-title":"International Journal of STD & AIDS"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD012021.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/01.aids.0000304695.54884.4f","article-title":"Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: A 3-year follow-up study","volume":"21","author":"Ruan","year":"2007","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/1471-2458-12-632","article-title":"The Cedar Project: high incidence of HCV infections in a longitudinal study of young Aboriginal people who use drugs in two Canadian cities","volume":"12","author":"Spittal","year":"2012","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1002\/14651858.CD012021.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF02386744","article-title":"Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area.","volume":"77","author":"Thiede","year":"2000","journal-title":"Journal of Urban Health"},{"issue":"7","key":"10.1002\/14651858.CD012021.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/aje\/155.7.645","article-title":"Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment","volume":"155","author":"Thorpe","year":"2002","journal-title":"American Journal of Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012021.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jamainternmed.2014.5416","article-title":"Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users","volume":"174","author":"Tsui","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012021.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/jech-2014-205070","article-title":"High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes","volume":"69","author":"Vallejo","year":"2015","journal-title":"Journal of Epidemiology & Community Health"},{"issue":"7156","key":"10.1002\/14651858.CD012021.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/bmj.317.7156.433","article-title":"Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study","volume":"317","author":"Beek","year":"1998","journal-title":"BMJ"},{"issue":"9","key":"10.1002\/14651858.CD012021.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","article-title":"Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users","volume":"102","author":"Berg","year":"2007","journal-title":"Addiction"},{"issue":"6","key":"10.1002\/14651858.CD012021.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5694\/mja13.00153","article-title":"Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study","volume":"201","author":"White","year":"2014","journal-title":"Medical Journal of Australia"},{"issue":"Spec No 1","key":"10.1002\/14651858.CD012021.pub2-BIB0032|cit32","first-page":"1S69","article-title":"New tools for preventing and evaluating risk practices for hepatitis C transmission among injection drug users: some reflections on injection rooms and the measurement of risk-taking behaviors","volume":"54","author":"Aubisson","year":"2006","journal-title":"Revue d'Epidemiologie et de Sante Publique"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-7517-2-22","article-title":"Effectiveness of harm reduction programmes for injecting drug users in Dhaka city","volume":"2","author":"Azim","year":"2005","journal-title":"Harm Reduction Journal"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1503\/cmaj.080808","article-title":"The cost-effectiveness of Vancouver's supervised injection facility","volume":"179","author":"Bayoumi","year":"2008","journal-title":"CMAJ"},{"issue":"3","key":"10.1002\/14651858.CD012021.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11524-007-9178-2","article-title":"Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004","volume":"84","author":"Burt","year":"2007","journal-title":"Urban Health"},{"issue":"6","key":"10.1002\/14651858.CD012021.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF03403970","article-title":"Methadone use in relation to hepatitis C virus testing in British Columbia","volume":"101","author":"Buxton","year":"2010","journal-title":"Canadian Journal of Public Health. Revue Canadienne de Sante Publique"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0790966700000665","article-title":"Opiate substitution prescribing in Belfast - two year follow up study","volume":"26","author":"Collins","year":"2009","journal-title":"Irish Journal of Psychological Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012021.pub2-BIB0038|cit38","first-page":"143","article-title":"Syringe exchanges: a public health response to problem drug use","volume":"93","author":"Cox","year":"2000","journal-title":"Irish Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5694\/j.1326-5377.1993.tb137822.x","article-title":"Hepatitis C virus infection among a cohort of Victorian injecting drug users","volume":"159","author":"Crofts","year":"1993","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/01.aids.0000192066.86410.8c","article-title":"Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001","volume":"19","author":"Jarlais","year":"2005","journal-title":"AIDS"},{"issue":"2","key":"10.1002\/14651858.CD012021.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/QAD.0b013e3280114a15","article-title":"Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City","volume":"21","author":"Jarlais","year":"2007","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0042|cit42","first-page":"78","article-title":"Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam: Evidence for harm reduction?","volume":"15","author":"Vos","year":"2012","journal-title":"Journal of the International AIDS Society"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0043|cit43","first-page":"22. Erratum in:","article-title":"Trends in drug consumption and risk of transmission of HIV and hepatitis C virus among injecting drug users in Switzerland, 1993-2006","volume":"13","author":"Dubois-Arber","year":"2008","journal-title":"Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0044|cit44","first-page":"616","article-title":"\"Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003\": Corrigendum","volume":"101","author":"Emmanuelli","year":"2006","journal-title":"Addiction"},{"issue":"11","key":"10.1002\/14651858.CD012021.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/j.1360-0443.2005.01271.x","article-title":"Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003","volume":"100","author":"Emmanuelli","year":"2005","journal-title":"Addiction"},{"issue":"20","key":"10.1002\/14651858.CD012021.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0025-7753(03)73839-1","article-title":"Prevalence of infection by HIV and hepatitis C virus in a cohort of patients on methadone treatment","volume":"120","author":"Esteban","year":"2003","journal-title":"Medicina Clinica"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11524-008-9330-7","article-title":"Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004","volume":"86","author":"Falster","year":"2009","journal-title":"Urban Health"},{"issue":"7","key":"10.1002\/14651858.CD012021.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1007\/s10461-011-0054-4","article-title":"Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy","volume":"16","author":"Fatseas","year":"2012","journal-title":"AIDS and Behavior"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012021.pub2-BIB0049|cit49","first-page":"IS26","article-title":"Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)","volume":"152","author":"Fhima","year":"2001","journal-title":"Annales De Medecine Interne (Paris)"},{"issue":"10","key":"10.1002\/14651858.CD012021.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/jurban\/jth084","article-title":"Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City","volume":"81","author":"Fuller","year":"2004","journal-title":"Journal of Urban Health"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-0676.1995.tb00672.x","article-title":"Hepatitis C virus infection in Italian intravenous drug users: Epidemiological and clinical aspects","volume":"15","author":"Galeazzl","year":"1995","journal-title":"Liver"},{"issue":"160-1","key":"10.1002\/14651858.CD012021.pub2-BIB0053|cit53","first-page":"25","article-title":"Evaluation of pilot methadone maintenance therapy in Georgia (Caucasus)","volume":"N\/A","author":"Gambashidze","year":"2008","journal-title":"Georgian Medical News"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012021.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/00042560-199802001-00004","article-title":"Prevalence and incidence of hepatitis C virus infection among young adult injection drug users","volume":"18","author":"Garfein","year":"1998","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"14","key":"10.1002\/14651858.CD012021.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/QAD.0b013e32823f9066","article-title":"A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users","volume":"21","author":"Garfein","year":"2007","journal-title":"AIDS"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/ije\/dyh019","article-title":"Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China","volume":"33","author":"Garten","year":"2004","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugpo.2011.05.015","article-title":"A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: Implications for new approaches in harm reduction and care","volume":"23","author":"Gervasoni","year":"2012","journal-title":"International Journal on Drug Policy"},{"issue":"2","key":"10.1002\/14651858.CD012021.pub2-BIB0058|cit58","first-page":"95","article-title":"Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high","volume":"1","author":"Goldberg","year":"1998","journal-title":"Communicable Disease and Public Health"},{"issue":"6","key":"10.1002\/14651858.CD012021.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/00365540152029936","article-title":"Trends in HCV prevalence among injecting drug users in Glasgow and Edinburgh during the era of needle\/syringe exchange","volume":"33","author":"Goldberg","year":"2001","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD012021.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.drugpo.2014.04.016","article-title":"An assessment of an HIV prevention intervention among People Who Inject Drugs in the states of Manipur and Nagaland, India","volume":"25","author":"Goswami","year":"2014","journal-title":"International Journal on Drug Policy"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/cid\/cit264","article-title":"Prevention and management of hepatitis C virus infection among people who inject drugs: moving the agenda forward. International Symposium on Hepatitis in Substance Users, Brussels, Belgium, 15-16 September 2011","volume":"57","author":"Grebely","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD012021.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"e97726","DOI":"10.1371\/journal.pone.0097726","article-title":"Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012","volume":"9","author":"Grebely","year":"2014","journal-title":"PLOS ONE"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0063|cit63","first-page":"1","article-title":"Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy","volume":"47","author":"Guadagnino","year":"1995","journal-title":"Journal of Clinical & Laboratory Immunology"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0064|cit64","first-page":"103","article-title":"Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs","volume":"77","author":"Hagan","year":"2000","journal-title":"Journal of Urban Health-Bulletin of the New York Academy of Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012021.pub2-BIB0065|cit65","first-page":"67","article-title":"Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond","volume":"113","author":"Heimer","year":"1999","journal-title":"Public Health"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0066|cit66","first-page":"33","article-title":"Hepatitis C incidence in the Melbourne injecting drug user cohort study: 2009-2012","volume":"31","author":"Higgs","year":"2012","journal-title":"Drug and Alcohol Review"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"296958","DOI":"10.1155\/2014\/296958","article-title":"Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in China and Thailand","volume":"2014","author":"Jackson","year":"2014","journal-title":"Hepatitis Research and Treatment"},{"issue":"2","key":"10.1002\/14651858.CD012021.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"e13484","DOI":"10.5812\/ircmj.13484","article-title":"The long-term effectiveness of methadone maintenance treatment in prevention of hepatitis C virus among illicit drug users: a modeling study","volume":"16","author":"Javanbakht","year":"2014","journal-title":"Iranian Red Crescent Medical Journal"},{"issue":"7481","key":"10.1002\/14651858.CD012021.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bmj.38286.841227.7C","article-title":"Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study","volume":"330","author":"Judd","year":"2005","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/QAI.0b013e3181a2539a","article-title":"The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis","volume":"51","author":"Kwon","year":"2009","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00126334-200104010-00014","article-title":"Changes in HIV-1 incidence in heroin users in Guangxi Province, China","volume":"26","author":"Lai","year":"2001","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2014.12.027","article-title":"Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: a 15-year observational cohort study","volume":"148","author":"Larney","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD012021.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/00365540050165875","article-title":"Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe\/needle exchange program","volume":"32","author":"Mansson","year":"2000","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0074|cit74","first-page":"S13","article-title":"Trajectories of injecting behaviour in the Amsterdam Cohort Study among drug users","volume":"28","author":"Mikolajczyk","year":"2013","journal-title":"European Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0075|cit75","first-page":"78","article-title":"The prevention of HIV infection and other blood-contact diseases among intravenous narcotic users in Nizhniy Novgorod within the framework of the Harm Reduction program","author":"Moshkovich","year":"2000","journal-title":"Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0376-8716(06)80005-0","article-title":"Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001","volume":"82","author":"Muga","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD012021.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1016\/j.ijid.2010.11.006","article-title":"Implications of hepatitis C viremia vs. antibody alone on transmission among male injecting drug users in three Afghan cities","volume":"15","author":"Nasir","year":"2011","journal-title":"International Journal of Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD012021.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/605947","article-title":"Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection","volume":"200","author":"Page","year":"2009","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"S463","DOI":"10.1016\/S0168-8278(11)61175-6","article-title":"Controlling hepatitis C virus (HCV): reinfection and intercalation and clearance of viremia in highly exposed young injectors","volume":"54","author":"Page","year":"2011","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD012021.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/cis921","article-title":"Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection","volume":"56","author":"Page","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/jvh.12117","article-title":"Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data","volume":"21","author":"Palmateer","year":"2014","journal-title":"Journal of Viral Hepatitis"},{"issue":"1-2","key":"10.1002\/14651858.CD012021.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drugalcdep.2010.02.010","article-title":"Predictors of crack cocaine initiation among Montreal street youth: a first look at the phenomenon","volume":"110","author":"Paquette","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1300\/J126v02n03_10","article-title":"Drug Court Fact Sheet: methadone maintenance and other pharmacotherapeutic interventions in the treatment of opioid dependence","volume":"2","author":"Parrino","year":"2003","journal-title":"Journal of Maintenance in the Addictions"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0084|cit84","first-page":"A50","article-title":"High incidence of hepatitis C virus resolution and reinfection in a cohort of injecting drugs users","volume":"28","author":"Pedrana","year":"2009","journal-title":"Drug and Alcohol Review"},{"issue":"3","key":"10.1002\/14651858.CD012021.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/ADM.0b013e31820e13dd","article-title":"Low risk for hepatitis C seroconversion in methadone maintenance treatment","volume":"5","author":"Peles","year":"2011","journal-title":"Journal of Addiction Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012021.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0272989X0102100502","article-title":"Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users","volume":"21","author":"Pollack","year":"2001","journal-title":"Medical Decision Making"},{"issue":"8","key":"10.1002\/14651858.CD012021.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2105\/AJPH.92.8.1254","article-title":"Hepatitis C screening and management practices: a survey of drug treatment and syringe exchange programs in New York City","volume":"92","author":"Pratt Udeagu","year":"2002","journal-title":"American Journal of Public Health"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1746.2003.03270.x","article-title":"Surveillance for newly acquired hepatitis C in Australia","volume":"19","author":"Robotin","year":"2004","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"17","key":"10.1002\/14651858.CD012021.pub2-BIB0089|cit89","first-page":"621","article-title":"Infection with hepatitis viruses HAV, HBV and HCV as well as with AIDS virus HIV in drug addicts of the Zurich street scene--a prevalence study","volume":"120","author":"Rohrig","year":"1990","journal-title":"Schweizerische Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/1471-2458-12-488","article-title":"Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial","volume":"12","author":"Roux","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1747-597X-9-37","article-title":"Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions","volume":"9","author":"Roux","year":"2014","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"1-3","key":"10.1002\/14651858.CD012021.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2009.01.006","article-title":"Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience","volume":"102","author":"Roy","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.drugalcdep.2012.05.018","article-title":"Injection of drug residue as a potential risk factor for HCV acquisition among Montreal young injection drug users","volume":"126","author":"Roy","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/OLQ.0b013e31827fd4d4","article-title":"Evaluation of harm reduction programs on seroincidence of HIV, hepatitis B and C, and syphilis among intravenous drug users in Southwest China","volume":"40","author":"Ruan","year":"2013","journal-title":"Sexually Transmitted Diseases"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"e81715","DOI":"10.1371\/journal.pone.0081715","article-title":"High HIV incidence among persons who inject drugs in Pakistan: greater risk with needle sharing and injecting frequently among the homeless","volume":"8","author":"Samo","year":"2013","journal-title":"PLOS ONE"},{"issue":"7","key":"10.1002\/14651858.CD012021.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/jmv.23575","article-title":"Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan","volume":"85","author":"Sanders-Buell","year":"2013","journal-title":"Journal of Medical Virology"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0097|cit97","first-page":"403A","article-title":"Determinants of hepatitis C viral RNA levels among a cohort of injection drug users with and without human immunodeficiency virus coinfection","volume":"40","author":"Seal","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1467-842X.1997.tb01664.x","article-title":"Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: Factors influencing hepatitis C serostatus","volume":"21","author":"Selvey","year":"1997","journal-title":"Australian and New Zealand Journal of Public Health"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1467-842X.1997.tb01664.x","article-title":"Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: Factors influencing hepatitis C serostatus","volume":"21","author":"Selvey","year":"1997","journal-title":"Australia and New Zealand Journal of Public Health"},{"issue":"2","key":"10.1002\/14651858.CD012021.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0376-8716(02)00316-2","article-title":"Intravenous opiate maintenance in a cohort of injecting drug addicts","volume":"69","author":"Sendi","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/archpediatrics.2009.241","article-title":"Survival sex work involvement as a primary risk factor for hepatitis C virus acquisition in drug-using youths in a Canadian setting","volume":"164","author":"Shannon","year":"2010","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/ADM.0b013e318156cc19","article-title":"The effect of methadone maintenance on illicit opioid use, human immunodeficiency virus and hepatitis C virus infection, health status, employment, and criminal activity among heroin abusers during 6 months of treatment in China","volume":"1","author":"Shi","year":"2007","journal-title":"Journal of Addiction Medicine"},{"issue":"11","key":"10.1002\/14651858.CD012021.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/aje\/kwq288","article-title":"Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India","volume":"172","author":"Solomon","year":"2010","journal-title":"American Journal of Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD012021.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2893.1997.00073.x","article-title":"Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission","volume":"4","author":"Spencer","year":"1997","journal-title":"Journal of Viral Hepatitis"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/eurpub\/11.4.425","article-title":"HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme","volume":"11","author":"Steffen","year":"2001","journal-title":"European Journal of Public Health"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/10550880903183034","article-title":"A trial to reduce hepatitis C seroincidence in drug users","volume":"28","author":"Stein","year":"2009","journal-title":"Journal of Addictive Diseases"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0107|cit107","first-page":"844A","article-title":"Is it worth testing unstable drug users for hepatitis C?","volume":"54","author":"Stephens","year":"2011","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0108|cit108","first-page":"1103A","article-title":"The natural history of the acquisition of HCV in chaotic PWID","volume":"58","author":"Stephens","year":"2013","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1097\/00002030-199708000-00001","article-title":"Needle exchange is not enough: Lessons from the Vancouver injecting drug use study","volume":"11","author":"Strathdee","year":"1997","journal-title":"AIDS"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.drugalcdep.2004.12.008","article-title":"The practice of office-based buprenorphine treatment of opioid dependence: Is it associated with new patients entering into treatment?","volume":"79","author":"Sullivan","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD012021.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00042737-200602000-00003","article-title":"Hepatitis C treatment in drug users: perception versus evidence","volume":"18","author":"Sylvestre","year":"2006","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1016\/S0168-8278(13)60500-0","article-title":"Dry blood spot testing for hepatitis C in people who injected drugs: reaching the populations other tests cannot reach","volume":"58","author":"Tait","year":"2013","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0113|cit113","first-page":"1102A","article-title":"People who inject drugs (PWID): difficult to get into services, easy to cure","volume":"58","author":"Tait","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"Article Number:","DOI":"10.1186\/s12954-015-0056-z","article-title":"Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan","volume":"12","author":"Todd","year":"2015","journal-title":"Harm Reduction Journal"},{"issue":"5","key":"10.1002\/14651858.CD012021.pub2-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"e004988","DOI":"10.1136\/bmjopen-2014-004988","article-title":"Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort","volume":"4","author":"Tracy","year":"2014","journal-title":"BMJ Open"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0116|cit116","first-page":"260","article-title":"Incidence of new HCV infection or reinfection after successful anti-HCV therapy among people who inject drugs attending a substitution treatment programme in northern Greece","volume":"15","author":"Tsirogianni","year":"2013","journal-title":"Suchtmedizin in Forschung und Praxis"},{"issue":"1-2","key":"10.1002\/14651858.CD012021.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.drugalcdep.2009.05.022","article-title":"Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco","volume":"105","author":"Tsui","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"2-3","key":"10.1002\/14651858.CD012021.pub2-BIB0118|cit118","first-page":"233","article-title":"High rates of transitions to injecting drug use among Mexican American non-injecting heroin users in San Antonio, Texas (never and former injectors)","volume":"114","author":"Valdez","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD012021.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00146260","article-title":"A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam","volume":"9","author":"Ameijden","year":"1993","journal-title":"European Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/infdis\/162.4.823","article-title":"Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam","volume":"162","author":"Hoek","year":"1990","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jhep.2009.05.027","article-title":"Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam","volume":"51","author":"Laar","year":"2009","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.1016\/S0168-8278(10)60676-9","article-title":"Long term follow-up of injecting drug users suggests protective immunity against HCV reinfection and superinfection with a similar genotype","volume":"52","author":"Laar","year":"2010","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0123|cit123","first-page":"235","article-title":"Temporal trends in mortality rates among drug users in Amsterdam compared to the general Dutch population differ by hepatitis C and HIV (co)infection status","volume":"15","author":"Santen","year":"2013","journal-title":"Suchtmedizin in Forschung und Praxis"},{"issue":"12","key":"10.1002\/14651858.CD012021.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1128\/jcm.35.12.3274-3277.1997","article-title":"Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland","volume":"35","author":"Villano","year":"1997","journal-title":"Journal of Clinical Microbiology"},{"issue":"12","key":"10.1002\/14651858.CD012021.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1111\/j.1360-0443.2009.02704.x","article-title":"Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: Implications for prevention policy and planning","volume":"104","author":"Wand","year":"2009","journal-title":"Addiction"},{"issue":"2","key":"10.1002\/14651858.CD012021.pub2-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"e87931","DOI":"10.1371\/journal.pone.0087931","article-title":"Long-term effects of methadone maintenance treatment with different psychosocial intervention models","volume":"9","author":"Wang","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0168-8278(09)60429-3","article-title":"Continued heavy transmission of HCV in a needle exchange program that is associated with minimal transmission of HIV. A nine year longitudinal cohort study","volume":"50","author":"Widell","year":"2009","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0128|cit128","first-page":"238","article-title":"The SWAN Project: integrating research and service with a cohort of young people who use drugs at risk for hepatitis C in New York City","volume":"15","author":"Winkelstein","year":"2013","journal-title":"Suchtmedizin in Forschung und Praxis"},{"issue":"17","key":"10.1002\/14651858.CD012021.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2008.574","article-title":"Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial","volume":"300","author":"Woody","year":"2008","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD012021.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1465-3362.2010.00258.x","article-title":"The Cedar Project: methadone maintenance treatment among young Aboriginal people who use opioids in two Canadian cities","volume":"30","author":"Yang","year":"2011","journal-title":"Drug and Alcohol Review"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1186\/1471-2458-12-1066","article-title":"Prevalences and associated risk factors of HCV\/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan","volume":"12","author":"Yen","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0132|cit132","first-page":"iv84","article-title":"Risk behaviors and HIV\/AIDS prevention education among IDUs in drug treatment in Shanghai","volume":"82","author":"Zhao","year":"2005","journal-title":"Urban Health"},{"issue":"5","key":"10.1002\/14651858.CD012021.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/add.12836","article-title":"Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China","volume":"110","author":"Zhou","year":"2015","journal-title":"Addiction"},{"issue":"8","key":"10.1002\/14651858.CD012021.pub2-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"e008162","DOI":"10.1136\/bmjopen-2015-008162","article-title":"Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study","volume":"5","author":"Zou","year":"2015","journal-title":"BMJ Open"},{"issue":"8","key":"10.1002\/14651858.CD012021.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1080\/00365540600617009","article-title":"HTLV-2 infection in injection drug users in King County, Washington","volume":"38","author":"Zunt","year":"2006","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD012021.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"S462","DOI":"10.1016\/S0168-8278(16)00775-3","article-title":"Effect of combined harm reduction strategies on HCV incidence among people who inject drugs in Montreal, Canada","volume":"64","author":"Bruneau","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0137|cit137","first-page":"251-5","article-title":"On the impact of community-based methadone maintenance treatment among drug addicts","volume":"22","author":"Chun","year":"2006","journal-title":"Journal of Preventive Medicine Information"},{"issue":"6","key":"10.1002\/14651858.CD012021.pub2-BIB0138|cit138","first-page":"552","article-title":"Study on the incidence and risk factors of HCV infection among heroin addicts who were on methadone maintenance treatment in Dehong prefecture,Yunnan province","volume":"34","author":"Duan","year":"2013","journal-title":"Zhonghua Liuxingbing Xue Zazhi [Chinese Journal of Epidemiology]"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0139|cit139","first-page":"343-6","article-title":"Community-based survey of drug use and sexual behavior among female injection drug users","volume":"9","author":"He","year":"2003","journal-title":"Zhongguo Aizibing Xingbing [Chinese Journal of AIDS & STD]"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0140|cit140","first-page":"80-3","article-title":"A survey of drug abuse and behaviors among injection drug users in Liangshan of Sichuan Province","volume":"10","author":"He","year":"2004","journal-title":"Zhongguo Yaowu Lanyong Fangzhi Zazhi [Chinese Journal of Drug Abuse Prevention andTreatment]"},{"issue":"2","key":"10.1002\/14651858.CD012021.pub2-BIB0141|cit141","first-page":"227","article-title":"Mitigating the burden of hepatitis C virus among people who inject drugs in Belgium","volume":"79","author":"Mathei","year":"2016","journal-title":"Acta Gastro-Enterologica Belgica"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0142|cit142","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s12913-016-1668-z.","article-title":"Individual-level needle and syringe coverage in Melbourne, Australia: a longitudinal, descriptive analysis","volume":"16","author":"O'Keefe","year":"2016","journal-title":"BMC Health Service Research"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1186\/s12889-015-2003-z","article-title":"HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India","volume":"15","author":"Ray Saraswati","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0144|cit144","first-page":"162","article-title":"Possibilities of drug addiction treatment during pregnancy","volume":"4","author":"Siedentopf","year":"2002","journal-title":"Suchtmedizin in Forschung und Praxis"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD012021.pub2-BIB0145|cit145","first-page":"326","article-title":"HCV infection among narcotics\/methamphetamine abusers","volume":"62","author":"Wada","year":"2004","journal-title":"Nippon Rinsho"},{"issue":"2","key":"10.1002\/14651858.CD012021.pub2-BIB0146|cit146","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003409.pub4","article-title":"Methadone at tapered doses for the management of opioid withdrawal","author":"Amato","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ije\/dyt243","article-title":"Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis","volume":"43","author":"Aspinall","year":"2014","journal-title":"International Journal of Epidemiology"},{"issue":"2-3","key":"10.1002\/14651858.CD012021.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drugalcdep.2006.12.035","article-title":"Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients","volume":"89","author":"Bluthenthal","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD012021.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"253","DOI":"10.17730\/humo.63.3.h1phxbhrb7m4mlv0","article-title":"The everyday violence of hepatitis C among young women who inject drugs in San Francisco","volume":"63","author":"Bourgois","year":"2004","journal-title":"Human Organization"},{"issue":"9737","key":"10.1002\/14651858.CD012021.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","article-title":"Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed","volume":"376","author":"Degenhardt","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD012021.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/jvh.12628","article-title":"Higher incidence of HCV in females compared to males who inject drugs: a systematic review and meta-analysis","volume":"24","author":"Esmaeili","year":"2016","journal-title":"Journal of Viral Hepatitis"},{"issue":"3","key":"10.1002\/14651858.CD012021.pub2-BIB0152|cit152","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002208","article-title":"Methadone maintenance at different dosages for opioid dependence","author":"Faggiano","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"14","key":"10.1002\/14651858.CD012021.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/00002030-199910010-00002","article-title":"Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users","volume":"13","author":"Gibson","year":"1999","journal-title":"Aids"},{"issue":"11","key":"10.1002\/14651858.CD012021.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00002030-200107270-00002","article-title":"Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users","volume":"15","author":"Gibson","year":"2001","journal-title":"AIDS"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012021.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"Journal of Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD012021.pub2-BIB0156|cit156","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004145.pub4","article-title":"Oral substitution treatment of injecting opioid users for prevention of HIV infection","author":"Gowing","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"The GRADE working group","year":"2004","journal-title":"BMJ"},{"issue":"7650","key":"10.1002\/14651858.CD012021.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","article-title":"A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs","volume":"204","author":"Hagan","year":"2011","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0161|cit161","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2893.2010.01297.x","article-title":"Incidence of HCV infection in PWID as measured via repeat testing such as detection of HCV RNA positive among HCV antibody negative results or antibody avidity","volume":"18","author":"Hope","year":"2010","journal-title":"Journal of Viral Hepatitis"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012021.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1097\/QAI.0000000000000659","article-title":"HIV, HCV and health-related harms among women who inject drugs: Implications for prevention and treatment","volume":"69","author":"Iversen","year":"2015","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0164|cit164","volume-title":"A review of the effectiveness and cost-effectiveness of needle and syringe programmes for injecting drug users","author":"Jones","year":"2008"},{"issue":"11","key":"10.1002\/14651858.CD012021.pub2-BIB0165|cit165","first-page":"1116","article-title":"A model-based estimate of HIV infectivity via needle sharing","volume":"5","author":"Kaplan","year":"1992","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"e5945","DOI":"10.1136\/bmj.e5945","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis","volume":"345","author":"MacArthur","year":"2012","journal-title":"BMJ"},{"issue":"9651","key":"10.1002\/14651858.CD012021.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"issue":"9719","key":"10.1002\/14651858.CD012021.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage","volume":"375","author":"Mathers","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD012021.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00126334-200406010-00012","article-title":"The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users","volume":"36","author":"Miller","year":"2004","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD012021.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1360-0443.2009.02888.x","article-title":"Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews","volume":"105","author":"Palmateer","year":"2010","journal-title":"Addiction"},{"issue":"4","key":"10.1002\/14651858.CD012021.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"Journal of Hepatology"},{"issue":"7","key":"10.1002\/14651858.CD012021.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","article-title":"Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis","volume":"16","author":"Platt","year":"2016","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0174|cit174","article-title":"Effectiveness of needle\/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs","volume":"1","author":"Platt","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012021.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1360-0443.2011.03765.x","article-title":"Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment","volume":"107","author":"Pouget","year":"2012","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0176|cit176","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"5","key":"10.1002\/14651858.CD012021.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1164\/rccm.200602-197ST","article-title":"An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations","volume":"174","author":"Sch\u00fcnemann","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0178|cit178","volume-title":"Extending the risk of bias tool to allow for assessment of non-randomised studies, clust-randomised trials and cross-over trials:a Cochrane methods innovation fund project (Workshop), 21st Cochrane Colloquium Abstract Book","author":"Sterne","year":"2013"},{"issue":"9737","key":"10.1002\/14651858.CD012021.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0140-6736(10)60743-X","article-title":"HIV and risk environment for injecting drug users: the past, present, and future","volume":"376","author":"Strathdee","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0180|cit180","volume-title":"Preventing HIV Infection among Injecting Drug Users in High-risk Countries: An Assessment of the Evidence","author":"Tilson","year":"2007"},{"issue":"11","key":"10.1002\/14651858.CD012021.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","article-title":"The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence","volume":"106","author":"Turner","year":"2011","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0182|cit182","volume-title":"Global Statistics. Fact Sheet","author":"UNAIDS","year":"2014"},{"issue":"11","key":"10.1002\/14651858.CD012021.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1111\/j.1360-0443.2012.03932.x","article-title":"Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings","volume":"107","author":"Vickerman","year":"2012","journal-title":"Addiction"},{"issue":"6","key":"10.1002\/14651858.CD012021.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.drugpo.2014.09.013","article-title":"Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modeling","volume":"25","author":"Vickerman","year":"2014","journal-title":"International Journal on Drug Policy"},{"issue":"7","key":"10.1002\/14651858.CD012021.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.addbeh.2013.03.009","article-title":"Participation in opioid substitution treatment reduces the rate of criminal convictions: evidence from a community study","volume":"38","author":"Vorma","year":"2013","journal-title":"Addictive Behaviors"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0186|cit186","volume-title":"Substitution maintenance therapy in the management of opiod dependence and HIV\/AIDS prevention: position paper","author":"World Health Organization","year":"2004"},{"issue":"6","key":"10.1002\/14651858.CD012021.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2105\/AJPH.2008.141846","article-title":"Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users","volume":"99","author":"Wiessing","year":"2009","journal-title":"American Journal of Public Health"},{"key":"10.1002\/14651858.CD012021.pub2-BIB0188|cit188","article-title":"Effectiveness of sterile needle and syringe programming in reducing HIV\/AIDS among injecting drug users","volume-title":"Evidence for Action Technical Papers","author":"Wodak","year":"2004"},{"issue":"2","key":"10.1002\/14651858.CD012021.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.amjmed.2006.02.030","article-title":"Frequent needle exchange use and HIV incidence in Vancouver, Canada","volume":"120","author":"Wood","year":"2007","journal-title":"American Journal of Medicine"},{"issue":"19","key":"10.1002\/14651858.CD012021.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1001\/jama.280.19.1690","article-title":"What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes","volume":"280","author":"Zhang","year":"1998","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD012021.pub2-BIB0191|cit191","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","article-title":"Effectiveness of needle\/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs","author":"Platt","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012021.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T13:19:08Z","timestamp":1693919948000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012021.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Drugs and Alcohol Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,9,18]]},"references-count":191,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012021.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,18]]}}}